Laurent Reber completed a Ph.D. at the University of Strasbourg in 2009, conducting research in the laboratory of Nelly Frossard. Following the completion of the Ph.D., they embarked on a postdoctoral fellowship in the laboratory of Steve Galli at Stanford University, where they focused on the biology of mast cells and their pivotal role in allergic diseases.

In 2016, Dr Reber was recruited by INSERM and joined the team led by Pierre Bruhns at Institut Pasteur in Paris. There, they continued their research endeavors, delving deeper into the mechanisms underlying allergic diseases and anaphylaxis.

In 2019, Dr Reber established the ATIP-Avenir team "Asthma, Allergy & Immunotherapy" at the INFINITy Institute in Toulouse, solidifying their commitment to advancing our understanding of these conditions. Notably, in 2022, they achieved the prestigious honor of receiving an ERC Consolidator Grant for their pioneering work in developing long-term therapeutic strategies to address IgE-mediated allergic diseases.

Seminar topic: New strategies for the diagnostic and treatment of allergic diseases